Sickle cell gene therapies offer new hope, but access remains a major challenge
Source:
cnbc
October 16, 2026 · 07:43
From the publisher
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
About the source
CNBC
The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…
Wikidata Q1023912
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →Netflix Scrambles to Rewrite Its Narrative With Layoffs and a Sudden Firing
nytimes
Oct 16, 2026 · 15:17
The Leap Second Is No More
wired
Oct 16, 2026 · 14:31
Replit is no longer working with Anthropic, CEO says
techcrunch
Oct 16, 2026 · 14:22
OpenAI models hacked a crypto wallet and breached more websites
arsTechnica
Oct 16, 2026 · 13:59
Why did CoreWeave stock get crushed this week? Look to this corner of the debt market for clues
cnbc
Oct 16, 2026 · 13:33